Mount Sinai Receives $1.7 Million to Study Natural Killer Cell Dysfunction in Bladder Cancer
September 12, 2019
September 12, 2019
NEW YORK, Sept. 12 -- The Ichan School of Medicine at Mount Sinai issued the following news release:
* * *
- The Tisch Cancer Institute Deepens Bladder Cancer Care With New Center of Excellence
* * *
The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called "natural killer" cells, or . . .
* * *
- The Tisch Cancer Institute Deepens Bladder Cancer Care With New Center of Excellence
* * *
The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called "natural killer" cells, or . . .